Non-alcoholic fatty liver disease (NAFLD), the world's most common chronic liver disease, is
increasingly linked to gut dysbiosis. Paneth cells secrete antimicrobial peptides that regulate …

Non-alcoholic steatohepatitis (NASH) is the severe form of non-alcoholic fatty liver disease,
and is characterized by liver inflammation and fat accumulation. Dietary interventions, such …

Gut microbiota plays an essential role in the progression of nonalcoholic fatty liver disease
(NAFLD), making the gut-liver axis a potential therapeutic strategy. Bacteroides genus, the …

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide, yet
the pathogenesis of NAFLD is only partially understood. Here, we investigated the role of the …

A beneficial gut Bacteroides-folate-liver pathway regulating lipid metabolism is
demonstrated. Oral administration of a Ganoderma meroterpene derivative (GMD) …

Background & Aims Periodontitis increases the risk of nonalcoholic fatty liver disease
(NAFLD); however, the underlying mechanisms are unclear. Here, we show that gut …

Non-alcoholic fatty liver disease (NAFLD) is a potentially severe liver disease that increases
evidence indicates that gut microbiota is related to it. In the study, 16S rRNA sequencing …

Non-alcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease
throughout the world. The relationship between gut microbiota and NAFLD has been …

Nonalcoholic fatty liver disease (NAFLD), characterized by excessive fat deposition in the
liver unrelated to alcohol consumption, is highly prevalent worldwide. However, effective …

Non-alcoholic fatty liver disease (NAFLD) is a metabolic disease closely associated with
dietary habits. Diosgenin is abundant in yam, a common food and traditional Chinese …